Description: This panel discussion is from the 1991 Meeting of the Society of Actuaries, held May 16-17 in New York. The panelists discuss various aspects of accelerated benefits, also known as “living benefits riders,” such as types of benefits, marketing, tax issues, pricing, valuation, and reinsurance. Regulatory issues are discussed, including the work of the American Council of Life Insurance, ‘ACLI,’ and the National Association of Insurance Commissioners, ‘NAIC,’ and their committees, in developing a Model Regulation. Discussion from participants is included. From the Record of Society of Actuaries, Volume 17, No. 2.

Description: This article provides a summary of selected sessions of the October 2010 NAIC meeting.

Description: This session from the 1995 SOA Boston Meeting covers an update on the current status of the proposed new standard non-forfeiture law for life insurance. From the Record of the Society of Actuaries, Vol. 21, No. 4a.

Description: Panelists at this session of the SOA 1998 Maui I Spring Meeting discuss the most current information on issues in the regulatory area that impact individual life and annuity products.

Description: Join us for this popular annual webcast covering the latest considerations for the year's U.S. statutory financial reporting work. Get ready to hear from three expert speakers, who will discuss cash flow testing and this year’s New York and California holiday letters, the impact of recent interest rate changes including treatment of negative IMR, potential changes to statutory financial reporting due to climate change, and updates regarding Principle Based Reserves.

Description: State insurance department actuary, who also is on two committees of the National Association of Insurance Commissioners [NAIC], discusses current NAIC activities regarding nonforfeiture, sales illustrations, and replacements for life products and sales illustrations for annuities, as well as equity-indexed annuities [EIAs]. From the 1997 Record of Society of Actuaries, Vol. 23, No. 3.

Description: This article is about equity indexed products sold by insurance companies, the regulatory scrutiny they are generating, and the initiatives being taken by actuaries to resolve these issues and concerns.